LOS ANGELES--(BUSINESS WIRE)--Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced it will release its 2006 fourth quarter and full-year financial results before the market opens on Monday, February 26, 2007. The company also said that senior management will host an investor conference call that same day at 8:30 a.m. PT/11:30 a.m. ET to review the company’s financial results and operations.
